Glycogen synthase kinase-3β negatively regulates TGF-β1 and Angiotensin II-mediated cellular activity through interaction with Smad3

European Journal of Pharmacology

Volumn 644, Issue 1-3, 2010, Pages 17-23

  Hua, Fang ^a   Zhou, Junlan ^a   Liu, Jinwen ^a   Zhu, Chuanjiang ^a   Cui, Bing ^a   Lin, Heng ^a   Liu, Yuying ^a   Jin, Wen ^a   Yang, Hongzhen ^a   Hu, Zhuowei ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Angiotensin II; Glycogen synthase kinase 3 ; Protein interaction; Smad3; Transforming growth factor 1

Indexed keywords

ANGIOTENSIN II; GLYCOGEN SYNTHASE KINASE 3BETA; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL STIMULATION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; CELL LINE; CELL LINE, TUMOR; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MYOCYTES, CARDIAC; PHOSPHORYLATION; RATS; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77955774208     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.06.042     Document Type: Article

References (25)

1. Antos C.L., McKinsey T.A., Frey N., Kutschke W., McAnally J., Shelton J.M., Richardson J.A., Hill J.A., Olson E.N. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:907-912.
2. Chi S.H., Mestril R. Stable expression of a human HSP70 gene in a rat myogenic cell line confers protection against endotoxin. Am. J. Physiol. Cell Physiol. 1996, 270:C1017-C1021.
3. Conery A.R., Cao Y., Thompson E.A., Townsend C.M., Ko T.C., Luo K. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis. Nat. Cell Biol. 2004, 6:366-372.
4. Du K., Herzig S., Kulkarni R.N., Montminy M. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 2003, 300:1574-1577.
5. Forde J.E., Dale T.C. Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol. Life Sci. 2007, 64:1930-1944.
6. Guo X., Ramirez A., Waddell D.S., Li Z., Liu X., Wang X.-F. Axin and GSK3-beta control Smad3 protein stability and modulate TGF-[beta] signaling. Genes Dev. 2008, 22:106-120.
7. Haq S., Choukroun G., Kang Z.B., Ranu H., Matsui T., Rosenzweig A., Molkentin J.D., Alessandrini A., Woodgett J., Hajjar R., Michael A., Force T. Glycogen synthase kinase-3-beta is a negative regulator of cardiomyocyte hypertrophy. J. Cell Biol. 2000, 151:117-130.
8. Hardt S.E., Sadoshima J. Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ. Res. 2002, 90:1055-1063.
9. Hata A., Lo R.S., Wotton D., Lagna G., Massague J. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature 1997, 388:82-87.
10. Ho J., Cocolakis E., Dumas V.M., Posner B.I., Laporte S.A., Lebrun J.J. The G protein-coupled receptor kinase-2 is a TGFbeta-inducible antagonist of TGFbeta signal transduction. EMBO J. 2005, 24:3247-3258.
11. Itoh S., Itoh F., Goumans M.-J., ten Dijke P. Signaling of transforming growth factor-beta family members through Smad proteins. Eur. J. Biochem. 2000, 267:6954-6967.
12. Jope R., Yuskaitis C., Beurel E. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem. Res. 2007, 32:577-595.
13. Massague J., Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 2000, 19:1745-1754.
14. Medunjanin S., Hermani A., De Servi B., Grisouard J., Rincke G., Mayer D. Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor-alpha and is involved in the regulation of receptor activity. J. Biol. Chem. 2005, 280:33006-33014.
15. Moustakas A., Souchelnytskyi S., Heldin C.-H. Smad regulation in TGF-beta signal transduction. J. Cell Sci. 2001, 114:4359-4369.
16. Nicolas F.J., Hill C.S. Attenuation of the TGF-beta-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-beta-induced growth arrest. Oncogene 2003, 22:3698-3711.
17. Pap M., Cooper G.M. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. 1998, 273:19929-19932.
18. Rodriguez-Vita J., Sanchez-Lopez E., Esteban V., Ruperez M., Egido J., Ruiz-Ortega M. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation 2005, 111:2509-2517.
19. Ruiz-Ortega M., Rodriguez-Vita J., Sanchez-Lopez E., Carvajal G., Egido J. TGF-beta signaling in vascular fibrosis. Cardiovasc. Res. 2007, 74:196-206.
20. Ryves W.J., Harwood A.J. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochem. Biophys. Res. Commun. 2001, 280:720-725.
21. Schroder D., Heger J., Piper H.M., Euler G. Angiotensin II stimulates apoptosis via TGF-beta1 signaling in ventricular cardiomyocytes of rat. J. Mol. Med. 2006, 84:975-983.
22. Sorescu D. Smad3 mediates angiotensin II- and TGF-beta1-induced vascular fibrosis: Smad3 thickens the plot. Circ. Res. 2006, 98:988-989.
23. Wang W., Huang X.R., Canlas E., Oka K., Truong L.D., Deng C., Bhowmick N.A., Ju W., Bottinger E.P., Lan H.Y. Essential role of Smad3 in Angiotensin II-induced vascular fibrosis. Circ. Res. 2006, 98:1032-1039.
24. Watcharasit P., Bijur G.N., Song L., Zhu J., Chen X., Jope R.S. Glycogen synthase kinase-3-beta (GSK3-beta) binds to and promotes the actions of p53. J. Biol. Chem. 2003, 278:48872-48879.
25. Zawel L., Dai J.L., Buckhaults P., Zhou S., Kinzler K.W., Vogelstein B., Kern S.E. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1998, 1:611-617.